Meyer T - Search Results

1

2,6,9-trisubstituted purines: optimization towards highly potent and selective CDK1 inhibitors.

Imbach P, Capraro HG, Furet P, Mett H, Meyer T, Zimmermann J. Imbach P, et al. Among authors: meyer t. Bioorg Med Chem Lett. 1999 Jan 4;9(1):91-6. doi: 10.1016/s0960-894x(98)00691-x. Bioorg Med Chem Lett. 1999. PMID: 9990463

2

Structure-based design and protein X-ray analysis of a protein kinase inhibitor.

Furet P, Meyer T, Strauss A, Raccuglia S, Rondeau JM. Furet P, et al. Among authors: meyer t. Bioorg Med Chem Lett. 2002 Jan 21;12(2):221-4. doi: 10.1016/s0960-894x(01)00715-6. Bioorg Med Chem Lett. 2002. PMID: 11755359

3

Chemical and biological profile of dual Cdk1 and Cdk2 inhibitors.

Ruetz S, Fabbro D, Zimmermann J, Meyer T, Gray N. Ruetz S, et al. Among authors: meyer t. Curr Med Chem Anticancer Agents. 2003 Jan;3(1):1-14. doi: 10.2174/1568011033353605. Curr Med Chem Anticancer Agents. 2003. PMID: 12678910 Review.

4

Identification of a new chemical class of potent angiogenesis inhibitors based on conformational considerations and database searching.

Furet P, Bold G, Hofmann F, Manley P, Meyer T, Altmann KH. Furet P, et al. Among authors: meyer t. Bioorg Med Chem Lett. 2003 Sep 15;13(18):2967-71. doi: 10.1016/s0960-894x(03)00626-7. Bioorg Med Chem Lett. 2003. PMID: 12941313

5

Entry into a new class of protein kinase inhibitors by pseudo ring design.

Furet P, Caravatti G, Guagnano V, Lang M, Meyer T, Schoepfer J. Furet P, et al. Among authors: meyer t. Bioorg Med Chem Lett. 2008 Feb 1;18(3):897-900. doi: 10.1016/j.bmcl.2007.12.041. Epub 2008 Jan 14. Bioorg Med Chem Lett. 2008. PMID: 18248988

6

[(Alkylamino)methyl]acrylophenones: potent and selective inhibitors of the epidermal growth factor receptor protein tyrosine kinase.

Traxler P, Trinks U, Buchdunger E, Mett H, Meyer T, Müller M, Regenass U, Rösel J, Lydon N. Traxler P, et al. Among authors: meyer t. J Med Chem. 1995 Jun 23;38(13):2441-8. doi: 10.1021/jm00013a020. J Med Chem. 1995. PMID: 7608909

7

Dianilinophthalimides: potent and selective, ATP-competitive inhibitors of the EGF-receptor protein tyrosine kinase.

Trinks U, Buchdunger E, Furet P, Kump W, Mett H, Meyer T, Müller M, Regenass U, Rihs G, Lydon N, et al. Trinks U, et al. Among authors: meyer t. J Med Chem. 1994 Apr 1;37(7):1015-27. doi: 10.1021/jm00033a019. J Med Chem. 1994. PMID: 8151612

8

4-(Phenylamino)pyrrolopyrimidines: potent and selective, ATP site directed inhibitors of the EGF-receptor protein tyrosine kinase.

Traxler PM, Furet P, Mett H, Buchdunger E, Meyer T, Lydon N. Traxler PM, et al. Among authors: meyer t. J Med Chem. 1996 Jun 7;39(12):2285-92. doi: 10.1021/jm960118j. J Med Chem. 1996. PMID: 8691423

9

Phenylamino-pyrimidine (PAP) derivatives: a new class of potent and selective inhibitors of protein kinase C (PKC).

Zimmermann J, Caravatti G, Mett H, Meyer T, Müller M, Lydon NB, Fabbro D. Zimmermann J, et al. Among authors: meyer t. Arch Pharm (Weinheim). 1996 Jul;329(7):371-6. doi: 10.1002/ardp.19963290707. Arch Pharm (Weinheim). 1996. PMID: 8764886

10

Design and synthesis of novel tyrosine kinase inhibitors using a pharmacophore model of the ATP-binding site of the EGF-R.

Traxler P, Furet P, Mett H, Buchdunger E, Meyer T, Lydon N. Traxler P, et al. Among authors: meyer t. J Pharm Belg. 1997 Mar-Apr;52(2):88-96. J Pharm Belg. 1997. PMID: 9193132 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,775 results

Search Page

Filters